undamentalytics Newsletter
Sign in

Natera, Inc. income statement

In fiscal 2025, Natera, Inc. reported revenue of $2.31bn, up 35.9% on the year before, operating income of −$310m (a -13.4% margin) and net income of −$208m, or −$1.52 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue551591902172112583023916258201,0831,6972,3062,707
Cost of revenue———134136158————————
Gross profit———8375100————————
Research and development12172842505151100264316321404624787
Selling, general and administrative32631101361551552063045115896188411,1771,255
Operating income−251−60−101−135−115−116−216−468−541−446−222−310−290
Interest expense2441410111589131144
Provision for credit losses————————0—————
Income before tax—−5−70−100−137−128−123−230−471−547−435−190−268−253
Income tax—0—000201101−60−60
Net income−37−5−70−100−138−128−125−230−472−548−435−190−208−192
Diluted EPS−$4.83−$0.54−$1.34−$1.95−$2.59−$2.22−$1.79−$2.84−$5.21−$5.57−$3.78−$1.53−$1.52−$1.37
Diluted shares (average)8m10m52m52m54m58m70m81m91m98m115m125m137m140m
EBITDA−236−54−95−128−107−109−208−457−524−422−191−268−239

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: EXEL vs NTRANTRA vs UTHRBNTX vs NTRAMRNA vs NTRA

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Natera, Inc.'s SEC filings (10-K and 10-Q), retrieved October 20, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Natera, Inc.